Sunday, October 25, 2009

Yahoo! News: Weight Loss News

Yahoo! News: Weight Loss News


Orexigen obesity drug shows added benefits: studies (Reuters)

Posted: 24 Oct 2009 10:01 AM PDT

Reuters - Nearly half of patients who completed 56 weeks of treatment with Orexigen Therapeutics Inc's experimental obesity treatment, Contrave, lost at least 10 percent of their weight in a late-stage study and the drug also appeared to help cholesterol and blood sugar levels.

No comments:

Post a Comment